{"id":"W2139468685","doi":"10.1093/annonc/mdt201.8","title":"Regard Phase 3, Randomized Trial of Ramucirumab in Patients with Metastatic Gastric or Gej Adenocarcinoma Following Progression on First-Line Chemotherapy","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Ramucirumab; Internal medicine; Hazard ratio; Clinical endpoint; Progression-free survival; Oncology; Cancer; Gastroenterology; Bevacizumab; Placebo; Phases of clinical research; Chemotherapy; Randomized controlled trial; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001334434,0.001404665,0.002687801,0.0003025745,0.0004303138,0.001309511,0.0008449845,0.001424631,0.005209919],"category_scores_gemma":[0.001383497,0.0005621618,0.002417498,0.0002952131,0.0009385008,0.001036789,0.00035995,0.003748908,0.0009593689],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009578263,"about_ca_system_score_gemma":0.0009443816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001233932,"about_ca_topic_score_gemma":0.004546157,"domain_scores_codex":[0.9995641,0.0002258974,0.00001859309,0.00008398105,0.00002497328,0.00008237697],"domain_scores_gemma":[0.9993869,0.0001624375,0.0001356302,0.00006058743,0.00003745364,0.0002170568],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9757568,0.003405345,0.001472561,0.0004397557,0.001333136,0.00006557551,0.00005322153,0.000514583,0.002179991,0.0001324445,0.001195602,0.01345103],"study_design_scores_gemma":[0.9422615,0.05179593,0.003327603,0.00003913332,0.0007290972,0.00005911362,0.00003358471,0.0004971121,0.0002910149,0.0001802916,0.0007693572,0.00001622281],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886835,0.004362752,0.000383007,0.0009512025,0.0006137847,0.001289177,0.0008931285,0.00011733,0.002705975],"genre_scores_gemma":[0.9908496,0.001532926,0.0008807332,0.001201647,0.0003570702,0.0009649021,0.001170869,0.00002597794,0.003016231],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005209919,"threshold_uncertainty_score":0.01742893,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05884592573580101,"score_gpt":0.3884167843187075,"score_spread":0.3295708585829065,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}